Nitric oxide protection against murine cerebral malaria is associated with improved cerebral microcirculatory physiology

Journal of Infectious Diseases

Volumn 203, Issue 10, 2011, Pages 1454-1463

  Cabrales, Pedro ^a,b   Zanini, Graziela M ^a,c   Meays, Diana ^a   Frangos, John A ^a   Carvalho, Leonardo J M ^a  

^a LA JOLLA BIOENGINEERING INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c Funda??o Oswaldo Cruz   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; DIPROPYLENETRIAMINE NONOATE; NITRIC OXIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIOLE; ARTICLE; BIOAVAILABILITY; BRAIN BLOOD FLOW; BRAIN MALARIA; CELL INTERACTION; CONTROLLED STUDY; DISEASE ASSOCIATION; HEMODYNAMICS; LEUKOCYTE; MOUSE; NONHUMAN; PATHOGENESIS; PIA ARTERY; PLASMODIUM BERGHEI; PRIORITY JOURNAL; VASOCONSTRICTION; VENULE;

ALKENES; ANIMALS; CEREBRAL HEMORRHAGE; CEREBRUM; HEMODYNAMICS; INFLAMMATION; MALARIA, CEREBRAL; MICE; MICE, INBRED C57BL; MICROCIRCULATION; NITRIC OXIDE; PLASMODIUM BERGHEI; VASOCONSTRICTION;

EID: 79955026263     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir058     Document Type: Article

References (50)

1. Rowe AK, Rowe SY, Snow RW, et al. The burden of malaria mortality among African children in the year 2000. Int J Epidemiol 2006; 35:691-704. (Pubitemid 43985563)
2. John CC, Bangirana P, Byarugaba J, et al. Cerebral malaria in children is associated with long-term cognitive impairment. Pediatrics 2008; 122:e92-9.
3. Pongponratn E, Turner GD, Day NP, et al. An ultrastructural study of the brain in fatal Plasmodium falciparum malaria. Am J Trop Med Hyg 2003; 69:345-59. (Pubitemid 38248267)
4. Beare NA, Harding SP, Taylor TE, Lewallen S, Molyneux ME. Perfusion abnormalities in children with cerebral malaria and malarial retinopathy. J Infect Dis 2009; 199:263-71.
5. Dondorp AM, Ince C, Charunwatthana P, et al. Direct in vivo assessment of microcirculatory dysfunction in severe falciparum malaria. J Infect Dis 2008; 197:79-84. (Pubitemid 351263470)
6. Yeo TW, Lampah DA, Gitawati R, et al. Impaired nitric oxide bioavailability and L-arginine reversible endothelial dysfunction in adults with falciparum malaria. J Exp Med 2007; 204:2693-704. (Pubitemid 350044792)
7. Yeo TW, Lampah DA, Tjitra E, et al. Relationship of cell-free hemoglobin to impaired endothelial nitric oxide bioavailability and perfusion in severe falciparum malaria. J Infect Dis 2009; 200:1522-9.
8. van der Heyde HC, Nolan J, Combes V, Gramaglia I, Grau GE. A unified hypothesis for the genesis of cerebral malaria: Sequestration, inflammation and hemostasis leading to microcirculatory dysfunction. Trends Parasitol 2006; 22:503-8. (Pubitemid 44479847)
9. Idro R, Jenkins NE, Newton CR. Pathogenesis, clinical features, and neurological outcome of cerebral malaria. Lancet Neurol 2005; 4:827-40. (Pubitemid 41619438)
10. Hunt NH, Grau GE. Cytokines: Accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol 2003; 9:491-9. (Pubitemid 37088152)
11. de Souza JB, Hafalla JC, Riley EM, Couper KN. Cerebral malaria: Why experimental murine models are required to understand the pathogenesis of disease. Parasitology 2009; 137:755-72.
12. Carvalho LJM. Murine cerebral malaria: How far from human cerebral malaria? Trends Parasitol 2010; 26:271-2.
13. Kennan RP, Machado FS, Lee SC, et al. Reduced cerebral blood flow and N-acetyl aspartate in a murine model of cerebral malaria. Parasitol Res 2005; 96:302-7. (Pubitemid 40941820)
14. Penet MF, Viola A, Confort-Gouny S, et al. Imaging experimental cerebral malaria in vivo: Significant role of ischemic brain edema. J Neurosci 2005; 25:7352-8. (Pubitemid 41129807)
15. Gramaglia I, Sobolewski P, Meays D, et al. Low nitric oxide bioavailability contributes to the genesis of experimental cerebral malaria. Nat Med 2006; 12:1417-22. (Pubitemid 44924501)
16. Conran N, Franco-Penteado CF, Costa FF. Newer aspects of the pathophysiology of sickle cell disease vaso-occlusion. Hemoglobin 2009; 33:1-16.
17. Toda N, Ayajiki K, Okamura T. Cerebral blood flow regulation by nitric oxide: Recent advances. Pharmacol Rev 2009; 61:62-97.
18. Cabrales P, Zanini GM, Meays D, Frangos JA, Carvalho LJM. Murine cerebral malaria is associated with a vasospasm-like microcirculatory dysfunction and survival upon rescue treatment is markedly increased by nimodipine. Am J Pathol 2010; 176:1306-15.
19. Pluta RM, Hansen-Schwartz J, Dreier J, et al. Cerebral vasospasm following subarachnoid hemorrhage: Time for a new world of thought. Neurol Res 2009; 31:151-8.
20. Bauer PR, Van Der Heyde HC, Sun G, Specian RD, Granger DN. Regulation of endothelial cell adhesion molecule expression in an experimental model of cerebral malaria. Microcirculation 2002; 9:463-70. (Pubitemid 135684856)
21. Belnoue E, Kayibanda M, Vigario AM, et al. On the pathogenic role of brain-sequestered alphabeta CD81 T cells in experimental cerebral malaria. J Immunol 2002; 169:6369-75. (Pubitemid 36903485)
22. Lackner P, Beer R, Heussler V, et al. Behavioural and histopathological alterations in mice with cerebral malaria. Neuropathol Appl Neurobiol 2006; 32:177-88.
23. Martins YC, Werneck GL, Carvalho LJ, et al. Algorithms to predict cerebral malaria in murine models using the SHIRPA protocol. Malar J 2010; 9:85-96.
24. Mostany R, Portera-Cailliau C. A craniotomy surgery procedure for chronic brain imaging. J Vis Exp 2008; 15:680.
25. Faraci FM. Role of endothelium-derived relaxing factor in cerebral circulation: Large arteries vs. microcirculation. Am J Physiol 1991; 261:H1038-42.
26. Kajita Y, Takayasu M, Suzuki Y, et al. Regional differences in cerebral vasomotor control by nitric oxide. Brain Res Bull 1995; 38:365-9.
27. You J, Johnson TD, Marrelli SP, Bryan RM Jr. Functional heterogeneity of endothelial P2 purinoceptors in the cerebrovascular tree of the rat. Am J Physiol 1999; 277:H893-900. (Pubitemid 29459601)
28. Bentley J, Rickaby D, Haworth ST, Hanger CC, Dawson CA. Pulmonary arterial dilation by inhaled NO: Arterial diameter, NO concentration relationship. J Appl Physiol 2001; 91:1948-54. (Pubitemid 33015041)
29. Kulik T, Kusano Y, Aronhime S, Sandler AL, Winn HR. Regulation of cerebral vasculature in normal and ischemic brain. Neuropharmacology 2008; 55:281-8.
30. Cabrales P, Tsai AG. Plasma viscosity regulates systemic and microvascular perfusion during acute extreme anemic conditions. Am J Physiol Heart Circ Physiol 2006; 291:H2445-52.
31. Sobolewski P, Gramaglia I, Frangos JA, Intaglietta M, van der Heyde H. Plasmodium berghei resists killing by reactive oxygen species. Infect Immun 2005; 73:6704-10. (Pubitemid 41368836)
32. Tsukahara H, Hori C, Hiraoka M, Mayumi M, Okada T, Gejyo F. Nitric oxide modulation of erythropoiesis in rats. Blood 1997; 90:473-4. (Pubitemid 27276597)
33. Kubes P, Suzuki M, Granger DN. Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991; 88:4651-5. (Pubitemid 21914599)
34. Zampolli A, Basta G, Lazzerini G, Feelisch M, De Caterina R. Inhibition of endothelial cell activation by nitric oxide donors. J Pharmacol Exp Ther 2000; 295:818-23.
35. Keynes RG, Garthwaite J. Nitric oxide and its role in ischaemic brain injury. Curr Mol Med 2004; 4:179-91. (Pubitemid 38425913)
36. Lackner P, Burger C, Pfaller K, et al. Apoptosis in experimental cerebral malaria: Spatial profile of cleaved caspase-3 and ultrastructural alterations in different disease stages. Neuropathol Appl Neurobiol 2007; 33:560-71. (Pubitemid 47390077)
37. Lara FA, Kahn SA, da Fonseca AC, et al. On the fate of extracellular hemoglobin and heme in brain. J Cereb Blood Flow Metab 2009; 29:1109-20.
38. Machado FS, Desruisseaux MS, Nagajyothi F, et al. Endothelin in a murine model of cerebral malaria. Exp Biol Med 2006; 231:1176-81. (Pubitemid 43845600)
39. Dietmann A, Lackner P, Helbok R, et al. Opposed circulating plasma levels of endothelin-1 and C-type natriuretic peptide in children with Plasmodium falciparum malaria. Malar J 2008; 7:253-9.
40. Desruisseaux MS, Machado FS, Weiss LM, Tanowitz HB, Golightly LM. Cerebral malaria: A vasculopathy. Am J Pathol 2010; 176:1075-8.
41. Srivastava K, Cockburn IA, Swaim A, et al. Platelet factor 4 mediates inflammation in experimental cerebral malaria. Cell Host Microbe 2008; 4:179-87.
42. Kurrek MM, Winkler M, Robinson DR, Zapol WM. Platelet factor 4 injection produces acute pulmonary hypertension in the awake lamb. Anesthesiology 1995; 82:183-7.
43. Lackner P, Hametner C, Beer R, et al. Complement factors C1q, C3 and C5 in brain and serum of mice with cerebral malaria. Malar J 2008; 7:207-15.
44. Patel SN, Berghout J, Lovegrove FE, et al. C5 deficiency and C5a or C5aR blockade protects against cerebral malaria. J Exp Med 2008; 205:1133-43. (Pubitemid 351679688)
45. Mügge A, Lopez JA, Heistad DD, Lichtlen PR. Vasoconstriction in response to activated leukocytes: Implications for vasospasm. Eur Heart J 1993; 14(suppl I):87-92. (Pubitemid 23362599)
46. Grau GE, Fajardo LF, Piguet PF, Allet B, Lambert PH, Vassalli P. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science 1987; 237:1210-12. (Pubitemid 17124914)
47. Megyeri P, Abrahám CS, Temesvá ri P, Kovács J, Vas T, Speer CP. Recombinant human tumor necrosis factor alpha constricts pial arterioles and increases blood-brain barrier permeability in newborn piglets. Neurosci Lett 1992; 148:137-40. (Pubitemid 23007723)
48. Beghdadi W, Porcherie A, Schneider BS, et al. Inhibition of histaminemediated signaling confers significant protection against severe malaria in mouse models of disease. J Exp Med 2008; 205:395-408. (Pubitemid 351281605)
49. Kaiser K, Texier A, Ferrandiz J, et al. Recombinant human erythropoietin prevents the death of mice during cerebral malaria. J Infect Dis 2006; 193:987-95.
50. Xiao L, Patterson PS, Yang C, Lal AA. Role of eicosanoids in the pathogenesis of murine cerebral malaria. Am J Trop Med Hyg 1999; 60:668-73. (Pubitemid 29233128)